Everett E. Vokes to Fallopian Tube Neoplasms
This is a "connection" page, showing publications Everett E. Vokes has written about Fallopian Tube Neoplasms.
Connection Strength
0.080
-
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecol Oncol. 2008 Jul; 110(1):49-55.
Score: 0.080